Item 2. PROPERTIES
1K characters. Original on sec.gov · Markdown
Item 2. PROPERTIES
As of December 31, 2023, Abbott owned or leased properties totaling approximately 44 million square feet, of which approximately 65% is owned by Abbott. Abbott’s principal corporate offices are located in Illinois and are owned by Abbott.
Abbott operates 90 manufacturing facilities globally. Abbott’s facilities are deemed suitable and provide adequate productive capacity. The manufacturing facilities are used by Abbott’s reportable segments as follows:
| Reportable Segments | Manufacturing Sites | |||||||
| Medical Devices | 31 | |||||||
| Diagnostic Products | 21 | |||||||
| Established Pharmaceutical Products | 24 | |||||||
| Nutritional Products | 14 | |||||||
| Worldwide Total | 90 |
Abbott’s research and development facilities in the United States are primarily located in California, Illinois, Minnesota, New Jersey, and Ohio. Abbott also has research and development facilities in various other countries, including Colombia, India, Singapore, Spain, and the United Kingdom.
There are no material encumbrances on the properties.
Previous: Item 1C. CYBERSECURITY · Next: Item 3. LEGAL PROCEEDINGS